Ratings by Citizens (Konstantinos Aprilakis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2018 | Loxo Oncology | LOXO | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/7/2018 | Syndax Pharmaceuticals | SNDX | Maintain | Market Outperform () |
|
Details | ||
| 10/22/2018 | Sutro Biopharma | STRO | New Coverage | Market Outperform (N/A) |
14.55 (8.01) |
-44.95% | Details | |
| 8/15/2018 | AnaptysBio | ANAB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2018 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details |
